OPNT

 
Common Stock
Nasdaq
Contact Info
  • 201 Santa Monica Boulevard
  • Suite 500
  • Santa Monica, CA 90401

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Latest Report Apr 30, 2017 10-Q
CIK 0001385508
Fiscal Year End 7/31
OTC Marketplace Not Available
Profile Data
SIC - Industry Classification Not Available
Incorporated In: NV, USA
Year of Inc. 2005
Employees 8 a/o Apr 17, 2017
Service Providers
Accounting/Auditing Firm
MaloneBailey, LLP
9801 Westheimer Road
Suite 1100
Houston, TX, 77042
United States
 
Securities Counsel
DLA Piper
Livingston Place West
Suite 1000
250 2nd St. SW
Calgary, ALB, T2P 0C1
Canada
 
Investor Relations Firm
Argot Partners
200 Park Avenue South
Suite 1515
New York, NY, 10003
United States
 
Company History
  • Formerly=Lightlake Therapeutics Inc. until 3-2016
  • Formerly=Madrona Ventures, Inc. until 10-2009
OPNT Security Details
Share Structure
Market Value1 $74,538,642 a/o Sep 20, 2017
Authorized Shares 200,000,000 a/o Sep 01, 2017
Outstanding Shares 2,026,608 a/o Sep 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s) Verified by Transfer Agent
VStock Transfer LLC
Shareholders
Shareholders of Record 148 a/o Oct 28, 2016
Short Selling Data
Short Interest 12,495 (719.88%)
Aug 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security